Altex-Alternatives To Animal Experimentation最新文献

{"title":"Determining a point of departure for skin sensitization potency and quantitative risk assessment of fragrance ingredients using the GARDskin dose-response assay.","authors":"Isabelle Lee, Andy Forreryd, Mihwa Na, Isabella Schember, Maura Lavelle, Robin Gradin, Ulrika Mattson, Henrik Johansson, Shashikiran Donthamsetty, Gregory Ladics, Anne Marie Api","doi":"10.14573/altex.2405131","DOIUrl":"https://doi.org/10.14573/altex.2405131","url":null,"abstract":"<p><p>Potency and quantitative risk assessment are essential for determining safe concentrations for the formulation of potential skin sensitizers into consumer products. Several new approach methodologies (NAMs) for skin sensitization hazard assessment have been developed, validated, and adopted in OECD test guidelines. However, work is ongoing to develop NAMs for predicting skin sensitization potency on a quantitative scale for use as a point of departure (POD) in next-generation risk assessment (NGRA). GARDskin Dose-Response (DR) is an adaptation of the validated GARDskin assay (OECD TG 442E), and the readout of the assay is a quantitative potency prediction similar to the No Expected Sensitization Induction Level (NESIL) value (µg/cm2). The goal of this study was to evaluate the performance of the GARDskin DR assay for potency prediction of fragrance ingredients. One hundred (100) fragrance ingredients from a reference database covering varied structural reactivity domains and potency were tested in GARDskin DR. Materials tested had varied protein-binding reactivity alerts, including Schiff base, Michael addition, SN2, and acylation. Potency categories were predicted with a total accuracy of 37% and an approximate accuracy (exact match or off by 1 category) of 81%. Combining predicted weak and very weak categories increased total accuracy to 53% and approximate accuracy to 98%. The mean prediction error for the NESIL and local lymph node assay (LLNA) EC3 was 3.15- and 3.36-fold, respectively. Based on the results of this study, GARDskin DR is a promising predictor of skin sensitization potency with an applicability domain covering a wide range of fragrance ingredient reaction mechanisms, increasing the confidence in using the assay to conduct NGRA, ultimately reducing the need for animal testing.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biology-inspired dynamic microphysiological system approaches to revolutionize basic research, healthcare and animal welfare.","authors":"Uwe Marx, Sonja Beken, Zaozao Chen, Eva-Maria Dehne, Ann Doherty, Lorna Ewart, Suzanne C Fitzpatrick, Linda G Griffith, Zhongze Gu, Thomas Hartung, James Hickman, Donald E Ingber, Seiichi Ishida, Jayoung Jeong, Marcel Leist, Lisa Levin, Donna L Mendrick, Giorgia Pallocca, Stefan Platz, Marian Raschke, Lena Smirnova, Danilo A Tagle, Martin Trapecar, Bas W M van Balkom, Janny van den Eijnden-van Raaij, Andries van der Meer, Adrian Roth","doi":"10.14573/altex.2410112","DOIUrl":"https://doi.org/10.14573/altex.2410112","url":null,"abstract":"<p><p>The regular workshops held by the Center for Alternatives to Animal Testing (CAAT) on biology-inspired microphysiological systems (MPS) taking place every four years, have become a reliable measure to assess fundamental scientific, industrial and regulatory trends for translational science in the MPS-field from a bird's eye view. The 2023 workshop participants at that time concluded that the technology as used within academia has matured significantly, underlined by the broad use of MPS and the steadily increasing number of high quality research publications - yet, broad industry adoption of MPS has been slow, despite strong interest. Academic research using MPS primarily aims to accurately recapitulate human biology in MPS-based organ models in areas where traditional models have been lacking key elements of human physiology, thereby enabling breakthrough discoveries for life sciences. Examples of these developments are summarized in the report presented here. In addition, we focus on key challenges identified during the previous workshop around progress made in bridging gaps between stakeholders between academia, regulatory agencies and industry on one hand, as well as overcoming hurdles to gain confidence in, and acceptance of MPS-derived data - the latter being of particular importance in a regulatory environment. The status of implementation of the recommendations detailed in the 2019 report have been reviewed. We conclude that communication between stakeholders has improved significantly, while recommendations related to regulatory acceptance still need to be implemented. Participants noted that the remaining challenges for increased translation of these technologies to industrial use and regulatory decision-making will not be fully solvable by basic academic research alone. Rather, more efforts into well-defined context-of-use qualifications are needed, together with increased standardization making MPS data more reliable and ultimately these novel tools economically more sustainable. The long-term roadmap from the 2015 workshop has been critically reviewed and updated. Recommendations for the next period and an outlook conclude the report.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AOPs to connect food additives' effects on gut microbiota to health outcomes.","authors":"Laure-Alix Clerbaux","doi":"10.14573/altex.2411271","DOIUrl":"10.14573/altex.2411271","url":null,"abstract":"<p><p>Gut microbiota play a central role in human health, notably through the production of metabolites, including short-chain fatty acids, secondary bile acids, vitamins or neurotransmitters. Beyond contributing to gut health, these microbial metabolites significantly impact multiple organ systems by activating key signaling pathways along the gut-organ axes, including the gut-liver, gut-brain, and gut-bone axes. Chemicals ingested through food such as food additives, extensively used to enhance the texture, preservation and appearance of foods, may interact with our gut microbiota, altering metabolite production, and this can have consequences for our health. However, gut microbial metabolism is currently overlooked in toxicology. While efforts are underway to develop standardized human-based new approach methodologies to assess compound-microbiome interactions, anchoring those assays within the adverse outcome pathway (AOP) framework would offer a structured way to connect changes in gut microbial metabolism to adverse health outcomes. Using human-based models enhances the relevance of the results while supporting the reduction of animal-based testing in toxicology research.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing.","authors":"Eike Cöllen, Kristina Bartmann, Jonathan Blum, Kelly Carstens, Ivana Celardo, Nivedita Chatterjee, Marco Corvaro, Nadine Dreser, Ellen Fritsche, Thomas Hartung, Helena T Hogberg, Thomas Knudsen, Katharina Koch, Anna Kreutz, Malene Lislien, Viktoria Magel, Sue M Marty, Giorgia Pallocca, Anna Bal-Price, Constanza Rovida, Magdalini Sachana, Timothy J Shafer, Lena Smirnova, Ilinca Suciu, Yaroslav Tanaskov, Silvia Tangianu, Chiara Wolfbeisz, Marcel Leist","doi":"10.14573/altex.2501091","DOIUrl":"10.14573/altex.2501091","url":null,"abstract":"<p><p>On occasion of the DNT5 meeting in Konstanz, Germany (April-2024), participants brainstormed on future challenges concerning a regulatory implementation of the developmental neurotoxicity (DNT) in vitro test battery (DNT-IVB). The five discussion topics below outline some of the key issues, opportunities and research directions for the next several years: (1) How to contextualize DNT hazard with information on potential maternal toxicity or other toxicity domains (non-DNT)? Several approaches on how to use cytotoxicity data from NAMs were discussed. (2) What opportunities exist for an immediate or near-future application of the DNT-IVB, e.g. as a prioritisation step or add-on to other information? Initial examples are already emerging; the data can be used even if the battery is not converted to a defined approach. (3) How to establish data interpretation procedures for multi-dimensional endpoints that reduce dimensionality and are suitable for classification? A decision framework is required on how to use the DNT-IVB in a regulatory context. Machine-learning (AI-approaches) may provide novel classification models. (4) How can a battery of molecular initiating events (MIEs) be smartly linked to the DNT-IVB? At what tier of an overall strategy would MIEs be evaluated, and how would one optimally balance cost vs information yield. (5) What is the way forward to scientific validation of DNT NAMs and the DNT-IVB? A large set of animal data would be required for conventional approaches, while mechanistic information may establish relevance in other ways</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Challenges and opportunities for validation of AI-based new approach methods.","authors":"Thomas Hartung, Nicole Kleinstreuer","doi":"10.14573/altex.2412291","DOIUrl":"https://doi.org/10.14573/altex.2412291","url":null,"abstract":"<p><p>The integration of artificial intelligence (AI) into new approach methods (NAMs) for toxicology rep-resents a paradigm shift in chemical safety assessment. Harnessing AI appropriately has enormous potential to streamline validation efforts. This review explores the challenges, opportunities, and future directions for validating AI-based NAMs, highlighting their transformative potential while acknowledging the complexities involved in their implementation and acceptance. We discuss key hurdles such as data quality, model interpretability, and regulatory acceptance, alongside opportunities including enhanced predictive power and efficient data integration. The concept of e-validation, an AI-powered framework for streamlining NAM validation, is presented as a comprehensive strategy to overcome limitations of traditional validation approaches, leveraging AI-powered modules for reference chemical selection, study simulation, mechanistic validation, and model training and evaluation. We propose robust validation strategies, including tiered approaches, performance benchmarking, uncertainty quantification, and cross-validation across diverse datasets. The importance of ongoing monitoring and refinement post-implementation is emphasized, addressing the dynamic nature of AI models. We consider ethical implications and the need for human oversight in AI-driven toxicology and outline the impact of trends in AI devel-opment, research priorities, and a vision for the integration of AI-based NAMs in toxicological practice, calling for collaboration among researchers, regulators, and industry stakeholders. We describe the vision of companion AI post-validation agents to keep methods and their validity status current. By addressing these challenges and opportunities, the scientific community can harness the potential of AI to enhance predictive toxicology while reducing reliance on traditional animal testing and increasing human relevance and translational capabilities.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":"42 1","pages":"3-21"},"PeriodicalIF":4.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum to National Workshop on Alternatives to Higher Animals in Toxicology and Biomedical Science.","authors":"Yasir H Siddique, Tanveer Beg, Himanshi Varshney, Iqra Subhan, Kajal Varshney, Javeria Fatima, Mohammad A Akbarsha","doi":"10.14573/altex.2403151e","DOIUrl":"https://doi.org/10.14573/altex.2403151e","url":null,"abstract":"<p><p>This corrects the article DOI: 10.14573/altex.2403151.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":"42 1","pages":"151"},"PeriodicalIF":4.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"State of the science on assessing developmental neurotoxicity using new approach methods.","authors":"Susan J Debad, Jason Aungst, Kelly Carstens, Marc Ferrer, Suzanne Fitzpatrick, Ellen Fritsche, Yijie Geng, Thomas Hartung, Helena T Hogberg, Rong Li, Iris Mangas, Sue Marty, Steven Musser, Monique Perron, Saniya Rattan, Joëlle Rüegg, Magdalini Sachana, Maren Schenke, Timothy J Shafer, Lena Smirnova, John Talpos, Robyn L Tanguay, Andrea Terron, Omari Bandele","doi":"10.14573/altex.2410231","DOIUrl":"10.14573/altex.2410231","url":null,"abstract":"<p><p>The workshop titled State of the Science on Assessing Developmental Neurotoxicity Using New Approach Methods was co-organized by University of Maryland’s Joint Institute for Food Safety and Applied Nutrition (JIFSAN) and the U.S. Food and Drug Administration’s (FDA) Center for Food Safety and Applied Nutrition (CFSAN; now called the Human Foods Program), and was hosted by FDA in College Park, MD on November 14-15, 2023. This event convened experts from inter­national organizations, governmental agencies, industry, and academia to explore the transition from traditional in vivo tests to innovative new approach methods (NAMs) in developmental neurotoxicity (DNT) testing. The discussions emphasized the heightened vulnerability of the developing human brain to toxic exposures and the potential of NAMs to provide more ethical, economical, and scientifically robust alternatives to traditional testing. Various NAMs for DNT were discussed, including in silico, in chemico, in vitro, non-mammalian whole organisms, and novel mammalian approaches. In addition to progress in the field, the workshop discussed ongoing chal­lenges such as expectations to perfectly replicate the complex biology of human neurodevelopment and integration of DNT NAMs into regulatory frameworks. Presentations and panel discussions pro­vided a comprehensive overview of the state of the science, assessed the capabilities and limitations of current DNT NAMs, and outlined critical next steps in advancing the field of DNT testing.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":"121-144"},"PeriodicalIF":4.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing a global education hub for animal-free innovation.","authors":"Monique R E Janssens, Daniela Salvatori, Janneke Hogervorst, Cristheena Nonis, Jarrod Bailey, Jeffrey Bajramovic, Anne Burgers, Francesca Caloni, Elza D van Deel, Janny van den Eijnden-van Raaij, Hossein E Amirabadi, Dilyana Filipova, Annalisa Gastaldello, Susan Gibbs, Birgit Goversen, Nicole Green, Jolanda van Hengel, Anne Kienhuis, Sjoukje van de Kolk, Carlo A Paggi, Louis C Penning, Francesca Pistollato, Silke Riegger, Merel Ritskes-Hoitinga, Maria P Vinardell","doi":"10.14573/altex.2411251","DOIUrl":"https://doi.org/10.14573/altex.2411251","url":null,"abstract":"","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":"42 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143061301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Virtual Human Platform for Safety Assessment (VHP4Safety) project: Next generation chemical safety assessment based on human data.","authors":"Anne Kienhuis, Cyrille Krul, Jacqueline van Engelen, Chris T Evelo, Ellen Hessel, Jarno Hoekman, Nynke Kramer, Esmeralda Krop, Rosalinde Masereeuw, Ellen Moors, Simona O Negro, Aldert H Piersma, Raymond Pieters, Marc Teunis, Egon L Willighagen, Juliette Legler","doi":"10.14573/altex.2407211","DOIUrl":"10.14573/altex.2407211","url":null,"abstract":"<p><p>The Virtual Human Platform for Safety Assessment (VHP4Safety) project aims to build a virtual human platform (VHP) to protect human health and revolutionize the safety assessment of chemicals and pharmaceuticals by transitioning from animal-based to human-based approaches. The goal of this article is to introduce the project and its interdisciplinary approach to co-creation with mul­tiple academic, regulatory, industrial and societal partners covering the entire safety assessment knowledge chain. Three research lines drive the project: 1) building the VHP; 2) feeding the VHP with human data; and 3) implementing the VHP. The project focusses on three case studies that incor­porate human-relevant scenarios not included in current animal-based safety assessment strategies. The VHP is built on tools and services, including pharmacokinetic and computational models, and integrates several data sources within each case study, including data on human physiology, epi­demiology, toxicokinetic and -dynamic parameters, as well as data on chemical characteristics and exposures. In addition, the VHP integrates new data generated within the project using new approach methodologies representing key events within adverse outcome pathways. Implemen­tation of the VHP is investigated using an innovation systems approach, engaging stakeholders, and organizing training and education. Central to the VHP4Safety project is our co-creative approach, which is facilitated by biannual designathons and hackathons that foster active involvement of all project participants from over 30 partner organizations. By integrating technological innovations with transparency and stakeholder collaboration, the VHP4Safety project will help shape the tran­sition to next generation safety assessment in which animal testing becomes redundant.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":"111-120"},"PeriodicalIF":4.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of gut permeability on estimation of oral bioavailability for chemicals in commerce and the environment.","authors":"Gregory S Honda, Elaina M Kenyon, Sarah Davidson-Fritz, Roger Dinallo, Hisham El Masri, Evgenia Korol-Bexell, Li Li, Derek Angus, Robert G Pearce, Risa R Sayre, Christopher Strock, Russell S Thomas, Barbara A Wetmore, John F Wambaugh","doi":"10.14573/altex.2403271","DOIUrl":"10.14573/altex.2403271","url":null,"abstract":"<p><p>Performance of pharmacokinetic models developed using in-vitro-to-in-vivo extrapolation (IVIVE) methods may be improved by refining assumptions regarding fraction absorbed (Fabs) through the intestine, a component of oral bioavailability (Fbio). Although in vivo measures of Fabs are often unavailable for non-pharmaceuticals, in vitro measures of apparent permeability (Papp) using the Caco-2 cell line have been highly correlated with Fabs. We measured bidirectional Papp for over 400 non-pharmaceutical chemicals using the Caco-2 assay. A random forest quantitative structure-property relationship (QSPR) model was developed using these and peer-reviewed pharmaceutical data. Both Caco-2 data (R2 = 0.37) and the QSPR model (R2 = 0.29) were better at predicting human bioavailability compared to in vivo rat data (R2 = 0.23). After incorporation into a high-throughput toxicokinetics (HTTK) framework for IVIVE, the Caco-2 data were used to estimate in vivo administered equivalent dose (AED) for bioactivity assessed in vitro. The HTTK-predicted plasma steady state concentrations (Css) for IVIVE were revised, with modest changes predicted for poorly absorbed chemicals. Experimental data were evaluated for sources of measurement uncertainty, which were then accounted for using the Monte Carlo method. Revised AEDs were subsequently compared with exposure estimates to evaluate effects on bioactivity:exposure ratios, a surrogate for risk. Only minor changes in the margin between chemical exposure and predicted bioactive doses were observed due to the preponderance of highly absorbed chemicals.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":" ","pages":"56-74"},"PeriodicalIF":4.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}